Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Lawrence Berkeley National Laboratory to Develop Nanocrystals for 3DIcon Under Department of Energy Contract

Abstract:
3DIcon Corporation (OTCBB:TDCP), a developer of volumetric, three-dimension projection and display technologies, today announced that it has signed a Materials Transfer Agreement ("MTA") with the regents of the University of California through the Lawrence Berkeley National Laboratory ("Berkeley Lab") under which Berkeley Lab will provide specialized nanocrystals to 3DIcon.

Lawrence Berkeley National Laboratory to Develop Nanocrystals for 3DIcon Under Department of Energy Contract

Tulsa, OK | Posted on July 20th, 2010

"We have completed and patented the rendering of 3D applications. Our focus now is to improve the resolution, color, and scalability of the images," said Martin Keating, 3DIcon's founder and CEO.



CSpace(R) is designed to provide true, full-color, high-resolution, volumetric 360-degree, three-dimensional images without any viewing aids such as special glasses. It is the first proven technology of its kind that has no mechanical moving parts. 3D display systems developed using CSpace will have the potential to enhance significantly such applications as medical imaging, surgical planning, full-body scans, aircraft manufacturing and maintenance, military command and control, baggage and cargo scanning, and entertainment. 3DIcon's current efforts include discussions with potential partners in furtherance of its goal of aggressively pursuing the commercialization of CSpace in a variety of applications.

Safe Harbor Statement Under The Private Securities Litigation Act Of 1995



With the exception of historical information, the matters discussed in this news release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of 3DIcon could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the company's operations, inability to hire and retain qualified personnel, and changes in the general economic climate. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, such statements should not be regarded as a representation by 3DIcon, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements.

####

About 3DIcon Corporation
3DIcon Corporation (the "Company") is a developer of groundbreaking 3D projection and display technologies that are designed to produce full color, 360-degree volumetric images, the "Next Step" in 3D display technologies. The Company has completed a working prototype of its flagship technology, CSpace(R), a breakthrough in 3D imaging. The Company has also launched its first software product, Pixel Precision(R), which targets the R&D market for developers using Texas Instruments' DLP(R) line of products.

For more information, please click here

Contacts:
3DIcon Corporation
Judy Keating
918-494-0505, extension 304

Copyright © 3DIcon Corporation

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

Display technology/LEDs/SS Lighting/OLEDs

Environmentally friendly photoluminescent nanoparticles for more vivid display colors: Osaka University-led researchers created a new type of light-emitting nanoparticle that is made of ternary non-toxic semiconductors to help create displays and LED lighting with better colors t August 29th, 2018

Carbon in color: First-ever colored thin films of nanotubes created: A method developed at Aalto University, Finland, can produce large quantities of pristine single-walled carbon nanotubes in select shades of the rainbow; the secret is a fine-tuned fabrication process -- and a s August 29th, 2018

Future electronic components to be printed like newspapers July 20th, 2018

DNA drives design principles for lighter, thinner optical displays: Lighter gold nanoparticles could replace thicker, heavier layered polymers used in displaysí back-reflectors June 27th, 2018

Materials/Metamaterials

How a tetrahedral substance can be more symmetrical than a spherical atom: A new type of symmetry September 14th, 2018

Peering into private life of atomic clusters -- using the world's tiniest test tubes September 6th, 2018

Cannibalistic materials feed on themselves to grow new nanostructures September 1st, 2018

Environmentally friendly photoluminescent nanoparticles for more vivid display colors: Osaka University-led researchers created a new type of light-emitting nanoparticle that is made of ternary non-toxic semiconductors to help create displays and LED lighting with better colors t August 29th, 2018

Announcements

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

New-Contracts/Sales/Customers

Nanometrics Delivers 100th: Atlas III System for Advanced Process Control Metrology Atlas III: Systems are qualified and in production for advanced devices in DRAM, 3D-NAND and Foundry/Logic August 2nd, 2018

Picosunís ALD solutions make quality watches tick July 26th, 2018

Barium ruthenate: A high-yield, easy-to-handle perovskite catalyst for the oxidation of sulfides July 13th, 2018

Oxford Instrumentsí 22 Tesla superconducting magnet system commissioned at the UAM, making it the most intense magnetic field available outside a large international facility July 12th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project